Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
From Aktis Oncology Inc.
Via GlobeNewswire
Tickers AKTS
News headline image
COMMVAULT INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Commvault Systems, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers CVLT
News headline image
SPORTRADAR LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sportradar Group AG and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers SRAD
News headline image
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Tickers BDTX
News headline image
Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
From Autolus Therapeutics plc
Via GlobeNewswire
Tickers AUTL
News headline image
Equus Announces First Quarter Net Asset Value
From Equus Total Return, Inc
Via GlobeNewswire
Tickers EQS
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers SES
News headline image
Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season
From Hitch Interactive
Via GlobeNewswire
News headline image
North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders
From North American Construction Group Ltd.
Via GlobeNewswire
Tickers NOA TSX:NOA
News headline image
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
From Eikon Therapeutics, Inc.
Via GlobeNewswire
Tickers EIKN
News headline image
Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026
From Remix Therapeutics
Via GlobeNewswire
News headline image
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers REGN
News headline image
Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
From Syndax Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers SNDX
News headline image
AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
From AerSale Inc
Via GlobeNewswire
Tickers ASLE
News headline image
Legend Biotech Announces Presentations at ASCO 2026
From Legend Biotech USA Inc.
Via GlobeNewswire
Tickers LEGN
News headline image
Navient declares second quarter common stock dividend
From Navient Corporation
Via GlobeNewswire
Tickers NAVI
News headline image
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
From Immuneering Corporation
Via GlobeNewswire
Tickers IMRX
News headline image
Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline
From Asher Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
From Bicara Therapeutics Inc.
Via GlobeNewswire
Tickers BCAX
News headline image
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
From Olema Oncology
Via GlobeNewswire
Tickers OLMA
News headline image
HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccRCC) at the Upcoming 2026 ASCO Annual Meeting
From HiberCell, Inc.
Via GlobeNewswire
News headline image
BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2026 ASCO Annual Meeting
From BlossomHill Therapeutics, Inc.
Via GlobeNewswire
News headline image
ATRARA (NASDAQ:ATRA) DEADLINE MAY 22nd: Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action Lawsuit
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ATRA
News headline image
COTY CLASS ACTION DEADLINE TOMORROW MAY 22nd: Bragar Eagel & Squire, P.C. Urges Coty, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 22nd
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers COTY
News headline image
The Math Underlying the Success of Tort Reforms – Florida Property Insurance and Beyond
From Demotech, Inc.
Via GlobeNewswire
News headline image
CVB Financial Corp. Names George A. Borba Jr. Chairman of the Board; Prior Chairman Hal W. Oswalt Transitions to Vice Chairman
From CVB Financial Corp
Via GlobeNewswire
Tickers CVBF
News headline image
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers RGC
News headline image
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
ROSEN, THE FIRST FILING FIRM, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers POET
News headline image
Viral Reddit Sensation My Gums Are Bleeding Expands into Graphic Novel, Merchandise Line, and Franchise Launch
From Salt Studio LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.